INFACET SYRUP

국가: 남아프리카

언어: 영어

출처: South African Health Products Regulatory Authority (SAHPRA)

제공처:

Sad-otc

환자 정보 전단

INDICATIONS [/za_1298.html#1]
  [/za_1298.html#1]     [/za_1298.html#1]
CONTRA-INDICATIONS [/za_1298.html#1]
      [/za_1298.html#1]
DOSAGE [/za_1298.html#1]
      [/za_1298.html#1]
SIDE-EFFECTS [/za_1298.html#1]
  [/za_1298.html#1]    PREGNANCY      [/za_1298.html#1]
OVERDOSE [/za_1298.html#1]

IDENTIFICATION [/za_1298.html#1]
  [/za_1298.html#1]    PATIENT INFORMATION
INFACET SYRUP
SCHEDULING STATUS:
S2
PROPRIETARY NAME
(and dosage form):
INFACET SYRUP
COMPOSITION:
Each 5 mL contains:

PROMETHAZINE 
Hydrochloride        7,0 mg

CODEINE 
Phosphate        5,0 mg

PARACETAMOL
        120,0 mg

PHENYLPROPANOLAMINE 
Hydrochloride        2,5 mg
        Alcohol 96 %        20,0 % v/v
PRESERVATIVES:
        Propyl hydroxybenzoate        0,01 % m/v
        Methyl hydroxybenzoate        0,10 % m/v
PHARMACOLOGICAL CLASSIFICATION:
A 2.8 Special Analgesic combinations.
PHARMACOLOGICAL ACTION:
Analgesic, antipyretic, decongestant syrup, for paediatric use.
INDICATIONS:
For the alleviation of mild to moderate pain and fever in infants and children and for nasal congestion associated with
colds, influenza and sinusitis.
CONTRA-INDICATIONS:
Infacet Syrup should not be used by epileptics or in conjunction with M.A.O. inhibitors. It must be used with caution in
patients with hepatic or kidney disease, cardiac disorders, hypertension, hyperthyroidism or diabetes mellitus. Contra-
indicated in cases of hypersensitivity to any of the ingredients.
WARNINGS:
1.        INFACET SYRUP SHOULD NOT BE USED CONTINUOUSLY FOR MORE THAN 10 DAYS WITHOUT CONSULTING YOUR DOCTOR.
2.        THIS MEDICINE MAY LEAD TO DROWSINESS AND IMPAIRED CONCENTRATION, WHICH MAY BE AGGRAVATED BY
SIMULTANEOUS INTAKE OF ALCOHOL OR OTHER